KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Interest & Investment Income: 2016-2024

Historic Interest & Investment Income for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to $425.0 million.

  • Moderna's Interest & Investment Income fell 29.13% to $73.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $335.0 million, marking a year-over-year decrease of 23.34%. This contributed to the annual value of $425.0 million for FY2024, which is 0.95% up from last year.
  • As of FY2024, Moderna's Interest & Investment Income stood at $425.0 million, which was up 0.95% from $421.0 million recorded in FY2023.
  • Over the past 5 years, Moderna's Interest & Investment Income peaked at $425.0 million during FY2024, and registered a low of $18.0 million during FY2021.
  • Over the past 3 years, Moderna's median Interest & Investment Income value was $421.0 million (recorded in 2023), while the average stood at $348.7 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 35.90% in 2020, then spiked by 1,011.11% in 2022.
  • Over the past 5 years, Moderna's Interest & Investment Income (Yearly) stood at $25.0 million in 2020, then fell by 28.00% to $18.0 million in 2021, then surged by 1,011.11% to $200.0 million in 2022, then surged by 110.50% to $421.0 million in 2023, then rose by 0.95% to $425.0 million in 2024.